The prevalence of atrial fibrillation (AF) is high in hemodialysis (HD) patients. It was suggested that oral anticoagulant therapy (OAT), the choice treatment for reducing the thromboembolic risk in AF patients, increases the incidence of both ischemic and hemorrhagic strokes in the HD population. Moreover, the therapy-related bleeding risk is particularly high in these patients. For these reasons there is no agreement on the use of OAT in HD patients with AF. The aim of this study was to evaluate the criteria adopted by nephrologists in prescribing OAT in HD patients with AF.All the patients presenting AF (paroxysmal, persistent or permanent) at 31/10/2010 (n = 290) were recruited from 1529 HD patients from ten Italian HD centres. To detect factors related to OAT administration the main clinical features, CHADS2 and HASBLED scores were evaluated in logistic regression models.The presence of permanent AF (OR = 4.28, p < 0.0001) was the only clinical factor directly associated to OAT ad...

Genovesi, S., Rossi, E., Pogliani, D., Gallieni, M., Stella, A., Badiali, F., et al. (2014). The nephrologist's anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation. JN. JOURNAL OF NEPHROLOGY, 27(2), 187-192 [10.1007/s40620-013-0030-3].

The nephrologist's anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation

GENOVESI, SIMONETTA CARLA
;
ROSSI, EMANUELA;STELLA, ANDREA;VALSECCHI, MARIA GRAZIA;
2014

Abstract

The prevalence of atrial fibrillation (AF) is high in hemodialysis (HD) patients. It was suggested that oral anticoagulant therapy (OAT), the choice treatment for reducing the thromboembolic risk in AF patients, increases the incidence of both ischemic and hemorrhagic strokes in the HD population. Moreover, the therapy-related bleeding risk is particularly high in these patients. For these reasons there is no agreement on the use of OAT in HD patients with AF. The aim of this study was to evaluate the criteria adopted by nephrologists in prescribing OAT in HD patients with AF.All the patients presenting AF (paroxysmal, persistent or permanent) at 31/10/2010 (n = 290) were recruited from 1529 HD patients from ten Italian HD centres. To detect factors related to OAT administration the main clinical features, CHADS2 and HASBLED scores were evaluated in logistic regression models.The presence of permanent AF (OR = 4.28, p < 0.0001) was the only clinical factor directly associated to OAT ad...
Articolo in rivista - Articolo scientifico
Atrial fibrillation; Bleeding; Hemodialysis; Oral anticoagulant therapy; Stroke;
atrial fibrillation, hemodialysis, oral anticoagulant therapy, stroke
English
2014
27
2
187
192
none
Genovesi, S., Rossi, E., Pogliani, D., Gallieni, M., Stella, A., Badiali, F., et al. (2014). The nephrologist's anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation. JN. JOURNAL OF NEPHROLOGY, 27(2), 187-192 [10.1007/s40620-013-0030-3].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/49970
Citazioni
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 11
Social impact